Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
G. Brett Moreau, Stacey L. Burgess, Jeffrey M. Sturek, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 3, pp. 1215-1219
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Fatai S. Oladunni, Jun‐Gyu Park, Paula A. Pino, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 368
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009195-e1009195
Open Access | Times Cited: 292
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
Pratima Kumari, Hussin A. Rothan, Janhavi P. Natekar, et al.
Viruses (2021) Vol. 13, Iss. 1, pp. 132-132
Open Access | Times Cited: 255
Animal and translational models of SARS-CoV-2 infection and COVID-19
Matt D. Johansen, Aaron T. Irving, Xavier Montagutelli, et al.
Mucosal Immunology (2020) Vol. 13, Iss. 6, pp. 877-891
Open Access | Times Cited: 176
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 152
IL-13 is a driver of COVID-19 severity
Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, et al.
JCI Insight (2021)
Open Access | Times Cited: 137
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus
Wenjuan Dong, Heather Mead, Lei Tian, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 136
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
Kun Li, David K. Meyerholz, Jennifer A. Bartlett, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 125
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
Scott E. Guimond, Courtney J. Mycroft‐West, Neha S. Gandhi, et al.
ACS Central Science (2022) Vol. 8, Iss. 5, pp. 527-545
Open Access | Times Cited: 88
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
Mariano Carossino, Devin Kenney, Aoife K. O’Connell, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 535-535
Open Access | Times Cited: 69
Type-I-interferon-responsive microglia shape cortical development and behavior
Caroline C. Escoubas, Leah C. Dorman, Phi T. Nguyen, et al.
Cell (2024) Vol. 187, Iss. 8, pp. 1936-1954.e24
Open Access | Times Cited: 46
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 93
COVID-19—Lessons Learned and Questions Remaining
Ferric C. Fang, Constance A. Benson, Carlos del Rı́o, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. 2225-2240
Open Access | Times Cited: 76
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
Ruikang Liu, Jeffrey L. Americo, Catherine A. Cotter, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 12
Open Access | Times Cited: 68
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
Ronit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 59
Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza
Linlin Bao, Wei Deng, Feifei Qi, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 58
Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis
Mostafa Eltobgy, Ashley Zani, Adam D. Kenney, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 46
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 43
The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19
Jide Tian, Daniel L. Kaufman
Biomedicines (2023) Vol. 11, Iss. 2, pp. 254-254
Open Access | Times Cited: 27
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Vaibhav Upadhyay, Rahul K. Suryawanshi, Preston Tasoff, et al.
mBio (2023)
Open Access | Times Cited: 25
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
Zhen Zhang, Li Zhou, Qianyun Liu, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
Sang Heui Seo, Yunyueng Jang
Vaccines (2020) Vol. 8, Iss. 4, pp. 584-584
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top